SS Innovations International, Inc. (NASDAQ: SSII), a developer of advanced robotic surgical systems, has entered into a $50 million at-the-market (“ATM”) equity offering program pursuant to an ATM Sales Agreement with Virtu Americas LLC. Under the agreement, the Company may offer and sell shares of its common stock from time to time through Virtu Americas, acting as exclusive sales agent or principal.
The ATM program is designed to provide SS Innovations with flexible access to capital to support general corporate purposes, with sales made at prevailing market prices as conditions permit. Under the terms of the agreement, Virtu Americas will receive a commission of up to 3.0% of the gross proceeds from shares sold through the program.
Lucosky Brookman LLP represented Virtu Americas LLC as counsel to the sales agent in connection with the transaction
